CUVL NASDAQ · Healthcare · FY 2025-06-30

Clinuvel Pharmaceuticals Ltd

Back to NASDAQ
0.03.36.69.913.2ABVfair 4.80buy —EPVfair 12.20buy ≤ 5.49EBVnot valid for this companyDBVnot valid for this companyprice 9.30 AUD
0.02.34.66.99.2ABVfair 3.35buy —EPVfair 8.51buy ≤ 3.83EBVnot valid for this companyDBVnot valid for this companyprice 6.49 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in AUDUSD
Verdict
Wait
Buy zone
Fair–Wait
Archetype
Franchise
Confidence
●●○ Medium · 2/4
Price
9.2966.490 AUDUSD *
Market cap
466.0M325.3M AUDUSD *
P / B
1.93
P / E
12.95
EPS
0.7180.501
DPS / yield
0.0500.035 (0.5%)
NAV / share
4.8013.351
Graham number
8.8106.150
Z'' score
16.01
Piotroski F
2 / 9
Beneish M
—
ROIC vs WACC
228.1% vs 9.1%

* Listed in USD — the pipeline states price and all valuations in the filing currency AUD (fx 1.43 AUD/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.